Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
DFCP1 Controls ATGL-Mediated Lipid Droplet Lipolysis in Star
2026-05-03
This study reveals that DFCP1 directly regulates lipid droplet (LD) catabolism by modulating ATGL recruitment and retention during cellular starvation. By elucidating how DFCP1 impedes LD lipolysis, the work advances understanding of nutrient-sensitive lipid metabolism, with implications for metabolic disease research and reliable protein complex analysis.
-
ECL Western Blotting Substrate: Technical Guide & Best Pract
2026-05-02
ECL Western Blotting Substrate (SKU K2187) addresses the need for sensitive, nonradioactive detection of horseradish peroxidase-conjugated proteins in chemiluminescent Western blot assays. It is optimal for protein detection workflows in molecular biology, cancer biology, and signal transduction pathway research, but should not be used in fluorescent or radioisotopic detection applications.
-
JC-1: Precision Tools for Mitochondrial Membrane Potential A
2026-05-01
Explore how JC-1, a gold-standard fluorescent probe, is reshaping translational research in mitochondrial dysfunction and apoptosis. Gain mechanistic insights, protocol optimization strategies, and strategic guidance for integrating JC-1 into high-impact workflows, with a special focus on its role in pulmonary fibrosis and ferroptosis inhibition.
-
Applied Use of G007-LK Tankyrase 1/2 Inhibitor in Cancer Mod
2026-05-01
G007-LK empowers researchers to dissect Wnt/β-catenin and Hippo signaling with nanomolar precision, enabling robust APC mutation colorectal cancer and hepatocellular carcinoma workflows. This article distills protocol enhancements, troubleshooting strategies, and real-world insights to ensure reproducible, high-impact results.
-
G-15: Precision G Protein-Coupled Estrogen Receptor Antagoni
2026-04-30
G-15 enables rigorous, selective inhibition of GPR30, empowering experimental dissection of rapid estrogen signaling and downstream pathway modulation. Leveraging robust solubility in DMSO and high specificity, G-15 optimizes workflows in cellular, molecular, and in vivo models—especially where classical estrogen receptor crosstalk must be excluded.
-
Translating 5-HT3 Antagonism: Alosetron in Gut Polarity Rese
2026-04-30
Explore how Alosetron, a selective 5-HT3 receptor antagonist, is powering new mechanistic research into gastrointestinal motility and epithelial polarity. This article blends molecular insight, experimental strategy, and translational context, connecting the latest findings in stem cell signaling with practical guidance for researchers using APExBIO's Alosetron.
-
Influenza Hemagglutinin (HA) Peptide: Precision Tag for Prot
2026-04-29
The Influenza Hemagglutinin (HA) Peptide stands out as a gold-standard epitope tag, streamlining immunoprecipitation, protein detection, and interaction studies with unmatched reliability. Discover how this high-purity, highly soluble HA tag peptide from APExBIO transforms experimental workflows and troubleshooting approaches in complex molecular biology applications.
-
Epalrestat Activates KEAP1/Nrf2 for Neuroprotection in PD Mo
2026-04-29
Jia et al. (2025) demonstrated that epalrestat, a clinically approved aldose reductase inhibitor, directly binds KEAP1 to activate the Nrf2 pathway, reducing oxidative stress and dopaminergic neuron loss in Parkinson's disease models. This work provides mechanistic evidence supporting the repurposing of epalrestat for neurodegenerative disease research and highlights its unique dual-action profile.
-
Gly-Gly-Phe-Gly (GGFG) Peptide: Precision Linker for Next-Ge
2026-04-28
Explore how Gly-Gly-Phe-Gly (GGFG) acts as a flexible, high-purity peptide linker advancing drug conjugation research and antibody-drug conjugate development. Discover unique mechanistic insights and protocol guidance that set this article apart from existing perspectives.
-
IPA-3: Precision Pak1 Inhibition for Advanced Kinase Assays
2026-04-28
IPA-3, a selective non-ATP-competitive Pak1 inhibitor, empowers researchers to dissect p21-activated kinase signaling with exceptional specificity. Explore how this tool—supplied by APExBIO—enables robust kinase activity assays, supports translational disease research, and delivers workflow reliability where precision matters most.
-
Sulfo-Cy3 NHS Ester: Illuminating Vascular Remodeling Pathwa
2026-04-27
This thought-leadership article explores how Sulfo-Cy3 NHS ester, a next-generation hydrophilic fluorescent dye, empowers translational vascular biology by enabling robust, precise, and reproducible fluorescent labeling of proteins and peptides. By integrating mechanistic insights from recent studies on endothelial cell plasticity and collateral circulation, the article provides strategic guidance on experimental design and workflow optimization for researchers advancing the frontiers of revascularization therapeutics.
-
PP2A-Regulated Autophagy Drives Drug Resistance in Candida a
2026-04-27
This study reveals that protein phosphatase 2A (PP2A) enhances Candida albicans biofilm drug resistance by promoting autophagy through ATG protein phosphorylation. These findings highlight autophagy as a critical regulatory mechanism, providing new insight into the development of antifungal resistance and potential therapeutic strategies.
-
Bafilomycin A1: Precision V-ATPase Inhibitor for Lysosomal R
2026-04-26
Bafilomycin A1 stands out as a gold-standard V-ATPase inhibitor, enabling scientists to dissect lysosomal function and autophagic flux with nanomolar resolution. Its proven selectivity and reversible action, as evidenced by advanced studies, streamline experimental workflows and enhance reproducibility in intracellular pH regulation and host-pathogen research.
-
Y-27632 Dihydrochloride: Advanced ROCK Inhibition in Cancer
2026-04-25
Explore the cutting-edge role of Y-27632 dihydrochloride, a potent ROCK inhibitor, in dissecting tumor invasion and metastasis pathways. This article provides advanced mechanistic insights and practical guidance for cancer research beyond conventional stem cell applications.
-
Semi-Automated Screening of Fast-Dissociating Anti-V5 Antibo
2026-04-24
Miyoshi et al. introduce a semi-automated single-molecule microscopy workflow to screen and identify fast-dissociating, specific monoclonal antibodies against protein tags, including the V5 epitope. Their method reveals that such antibodies are more common than expected and enables new applications in super-resolution imaging and dynamic protein studies.